Non-Steroidal Anti-Inflammatory Drugs Increase the Antiretroviral Activity of Nucleoside Reverse Transcriptase Inhibitors in HIV Type-1-Infected T-Lymphocytes: Role of Multidrug Resistance Protein 4

Durant J. , Clevenbergh P. , Halfon P. Drug-resistance genotyping in HIV-1 therapy: the VIRADAPT randomised controlled trial. Lancet 1999; 353: 2195–2199.

Groschel B. , Cinatl J. , Cinatl J. Jr. , Viral and cellular factors for resistance against antiretroviral agents. Intervirology 1997; 40: 400–407.

Hoggard P.G. , Owen A. The mechanisms that control intracellular penetration of the HIV protease inhibitors. J Antimicrob Chemother 2003; 51: 493–496.

Schuetz J.D. , Connelly M.C. , Sun D. MRP4: A previously unidentified factor in resistance to nucleoside-based antiviral drugs. Nat Med 1999; 5: 1048–1051.

Borst P. , Elferink R.O. Mammalian ABC transporters in health and disease. Annu Rev Biochem 2002; 71: 537–592.

Russel F.G. , Koenderink J.B. , Masereeuw R. Multidrug resistance protein 4 (MRP4/ABCC4): a versatile efflux transporter for drugs and signalling molecules. Trends Pharmacol Sci 2008; 29: 200–207.

Leslie E.M. , Deeley R.G. , Cole S.P. Toxicological relevance of the multidrug resistance protein 1, MRP1 (ABCC1) and related transporters. Toxicology 2001; 167: 3–23.

Konig J. , Nies A.T. , Cui Y. , Leier I. , Keppler D. Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance. Biochim Biophys Acta 1999; 1461: 377–394.

Haimeur A. , Conseil G. , Deeley R.G. , Cole S.P. The MRP-related and BCRP/ABCG2 multidrug resistance proteins: biology, substrate specificity and regulation. Curr Drug Metab 2004; 5: 21–53.

Dallas S. , Miller D.S. , Bendayan R. Multidrug resistance-associated proteins: expression and function in the central nervous system. Pharmacol Rev 2006; 58: 140–161.

Borst P. , de Wolf C. , van de Wetering K. Multidrug resistance-associated proteins 3, 4, and 5. Pflugers Arch 2007; 453: 661–673.

Guo Y. , Kotova E. , Chen Z.S. MRP8, ATP-binding cassette C11 (ABCC11), is a cyclic nucleotide efflux pump and a resistance factor for fluoropyrimidines 2’,3’-dideoxycytidine and 9’-(2’-phosphonylmethoxyethyl) adenine. J Biol Chem 2003; 278: 29509–29514.

Kruh G.D. , Belinsky M.G. The MRP family of drug efflux pumps. Oncogene 2003; 22: 7537–7552.

Srinivas R.V. , Middlemas D. , Flynn P. , Fridland A. Human immunodeficiency virus protease inhibitors serve as substrates for multidrug transporter proteins MDR1 and MRP1 but retain antiviral efficacy in cell lines expressing these transporters. Antimicrob Agents Chemother 1998; 42: 3157–3162.

Jones K. , Bray P.G. , Khoo S.H. P-Glycoprotein and transporter MRP1 reduce HIV protease inhibitor uptake in CD4 cells: potential for accelerated viral drug resistance? AIDS 2001; 15: 1353–1358.

Janneh O. , Owen A. , Chandler B. Modulation of the intracellular accumulation of saquinavir in peripheral blood mononuclear cells by inhibitors of MRP1, MRP2, P-gp and BCRP. AIDS 2005; 19: 2097–2102.

Reid G. , Wielinga P. , Zelcer N. Characterization of the transport of nucleoside analog drugs by the human multidrug resistance proteins MRP4 and MRP5. Mol Pharmacol 2003; 63: 1094–1103.

Wijnholds J. , Mol C.A. , van Deemter L. Multidrug-resistance protein 5 is a multispecific organic anion transporter able to transport nucleotide analogs. Proc Natl Acad Sci U S A 2000; 97: 7476–7481.

Dallas S. , Schlichter L. , Bendayan R. Multidrug resistance protein (MRP) 4- and MRP 5-mediated efflux of 9-(2-phosphonylmethoxyethyl)adenine by microglia. J Pharmacol Exp Ther 2004; 309: 1221–1229.

Imaoka T. , Kusuhara H. , Adachi M. Functional involvement of multidrug resistance-associated protein 4 (MRP4/ABCC4) in the renal elimination of the antiviral drugs adefovir and tenofovir. Mol Pharmacol 2007; 71: 619–627.

Vane J.R. , Bakhle Y.S. , Botting R.M. Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol 1998; 38: 97–120.

Han S. , Inoue H. , Flowers L.C. , Sidell N. Control of COX-2 gene expression through peroxisome proliferator-activated receptor gamma in human cervical cancer cells. Clin Cancer Res 2003; 9: 4627–4635.

Stichtenoth D.O. , Wagner B. , Frolich J.C. Effects of meloxicam and indomethacin on cyclooxygenase pathways in healthy volunteers. J Investig Med 1997; 45: 44–49.

Tegeder I. , Pfeilschifter J. , Geisslinger G. Cyclooxygenase-independent actions of cyclooxygenase inhibitors. FASEB J 2001; 15: 2057–2072.

Reid G. , Wielinga P. , Zelcer N. The human multidrug resistance protein MRP4 functions as a prostaglandin efflux transporter and is inhibited by nonsteroidal antiinflammatory drugs. Proc Natl Acad Sci U S A 2003; 100: 9244–9249.

Turriziani O. , Pagnotti P. , Pierangeli A. The effects of prolonged treatment with zidovudine, lamivudine, and abacavir on a T-lymphoblastoid cell line. AIDS Res Hum Retroviruses 2006; 22: 960–967.

Turriziani O. , Schuetz J.D. , Focher F. Impaired 2’,3’-dideoxy-3’-thiacytidine accumulation in T-lymphoblastoid cells as a mechanism of acquired resistance independent of multidrug resistant protein 4 with a possible role for ATP-binding cassette C11. Biochem J 2002; 368: 325–332.

Warner T.D. , Mitchell J.A. Nonsteroidal antiinflammatory drugs inhibiting prostanoid efflux: as easy as ABC? Proc Natl Acad Sci U S A 2003; 100: 9108–9110.

Courtois A. , Payen L. , Lagadic D. , Guillouzo A. , Fardel O. Evidence for a multidrug resistance-associated protein 1 (MRP1)-related transport system in cultured rat liver biliary epithelial cells. Life Sci 1999; 64: 763–774.

Payen L. , Courtois A. , Vernhet L. , Guillouzo A. , Fardel O. The multidrug resistance-associated protein (MRP) is over-expressed and functional in rat hepatoma cells. Int J Cancer 1999; 81: 479–485.

Turriziani O. , Gianotti N. , Falasca F. Expression levels of MDR1, MRP1, MRP4, and MRP5 in peripheral blood mononuclear cells from HIV infected patients failing antiretroviral therapy. J Med Virol 2008; 80: 766–771.

Iniguez M.A. , Punzon C. , Fresno M. Induction of cyclooxygenase-2 on activated T lymphocytes: regulation of T cell activation by cyclooxygenase-2 inhibitors. J Immunol 1999; 163: 111–119.

Swanstrom R. , Erona J. Human immunodeficiency virus type-1 protease inhibitors: therapeutic successes and failures, suppression and resistance. Pharmacol Ther 2000; 86: 145–170.

Deeley R.G. , Westlake C. , Cole S.P. Transmembrane transport of endo- and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins. Physiol Rev 2006; 86: 849–899.

Chen Z.S. , Lee K. , Kruh G.D. Transport of cyclic nucleotides and estradiol 17-beta-D-glucuronide by multidrug resistance protein 4. Resistance to 6-mercaptopurine and 6-thioguanine. J Biol Chem 2001; 276: 33747–33754.

van Aubel R.A. , Smeets P.H. , Peters J.G. , Bindels R.J. , Russel F.G. The MRP4/ABCC4 gene encodes a novel apical organic anion transporter in human kidney proximal tubules: putative efflux pump for urinary cAMP and cGMP. J Am Soc Nephrol 2002; 13: 595–603.

Wielinga P.R. , van der Heijden I. , Reid G. Characterization of the MRP4- and MRP5-mediated transport of cyclic nucleotides from intact cells. J Biol Chem 2003; 278: 17664–17671.

Jedlitschky G. , Tirschmann K. , Lubenow L.E. The nucleotide transporter MRP4 (ABCC4) is highly expressed in human platelets and present in dense granules, indicating a role in mediator storage. Blood 2004; 104: 3603–3610.

El-Sheikh A.A. , van den Heuvel J.J. , Koenderink J.B. , Russel F.G. Interaction of nonsteroidal anti-inflammatory drugs with multidrug resistance protein (MRP) 2/ABCC2- and MRP4/ABCC4-mediated methotrexate transport. J Pharmacol Exp Ther 2007; 320: 229–235.

Sassi Y. , Lipskaia L. , Vandecasteele G. Multidrug resistance-associated protein 4 regulates cAMP-dependent signaling pathways and controls human and rat SMC proliferation. J Clin Invest 2008; 118: 2747–2757.

Norris M.D. , Smith J. , Tanabe K. Expression of multidrug transporter MRP4/ABCC4 is a marker of poor prognosis in neuroblastoma and confers resistance to irinotecan in vitro. Mol Cancer Ther 2005; 4: 547–553.

Chandler B. , Almond L. , Ford J. The effects of protease inhibitors and nonnucleoside reverse transcriptase inhibitors on p-glycoprotein expression in peripheral blood mononuclear cells in vitro. J Acquir Immune Defic Syndr 2003; 33: 551–556.

Maher J.M. , Dieter M.Z. , Aleksunes L.M. Oxidative and electrophilic stress induces multidrug resistance-associated protein transporters via the nuclear factor-E2-related factor-2 transcriptional pathway. Hepatology 2007; 46: 1597–1610.

Gradilone A. , Pulcinelli F.M. , Lotti L.V. Celecoxib induces MRP-4 in lung cancer cells: therapeutic implications. J Clin Oncol 2007; 25: 4318–4320, author reply 4320.

Jorajuria S. , Dereuddre-Bosquet N. , Becher F. ATP binding cassette multidrug transporters limit the anti-HIV activity of zidovudine and indinavir in infected human macrophages. Antivir Ther 2004; 9: 519–528.

Takada Y. , Bhardwaj A. , Potdar P. , Aggarwal B.B. Nonsteroidal anti-inflammatory agents differ in their ability to suppress NF-kappaB activation, inhibition of expression of cyclooxygenase-2 and cyclin D1, and abrogation of tumor cell proliferation. Oncogene 2004; 23: 9247–9258.

Jorajuria S. , Dereuddre-Bosquet N. , Naissant-Storck K. , Dormont D. , Clayette P. Differential expression levels of MRP1, MRP4, and MRP5 in response to human immunodeficiency virus infection in human macrophages. Antimicrob Agents Chemother 2004; 48: 1889–1891.